Operative complications and economic outcomes of cholecystectomy for acute cholecystitis

Table 2 Stratification by disease severity using 2013/18 Tokyo guidelines, n (%)

	Same admission cholecystectomy, n = 486	Delayed cholecystectomy, n = 68	P value
Acute cholecystitis severity
Tokyo Grade 1	299 (61.5)	36 (52.9)	0.271
Tokyo Grade 2	174 (35.8)	31 (45.6)
Tokyo Grade 3	13 (2.7)	1 (1.5)
Tokyo criteria	mean ± SD	mean ± SD
White blood cell count	11.8 ± 4.5	11.4 ± 3.8	0.605
Duration of complaints	1.9 ± 7.3	1.4 ± 3.2	0.578
Palpable tender mass in RUQ	8 (1.6)	1 (1.5)	1
Marked local inflammation	66 (13.6)	13 (19.1)	0.221
Creatinine	0.9 ± 0.8	0.7 ± 0.2	0.104
International normalized ratio	1.1 ± 0.2	1.4 ± 0.7	0.534
Platelet count	271.9 ± 73.8	282.6 ± 92.0	0.633
Cardiovascular dysfunction	2 (0.41)	0 (0.0)	1
Neurological dysfunction	0 (0.0)	0 (0.0)	1
Respiratory dysfunction	0 (0.0)	0 (0.0)	1
Other vitals and laboratory values
Temperature (˚C)	36.7 ± 0.4	36.6 ± 0.4	0.068
Total bilirubin	1.0 ± 1.4	1.1 ± 1.7	0.852
Direct bilirubin	0.1 ± 0.6	0.5 ± 1.5	0.474
Aspartate aminotransferase	89.5 ± 181.6	64 ± 100.6	0.32
Alanine aminotransferase	94.9 ± 181.8	70.0 ± 96.4	0.32
Alkaline phosphatase	102.3 ± 48.6	111.4 ± 69.6	0.591
Amylase	87.6 ± 235.5	54 ± 5.3	0.112
Lipase	207.6 ± 704.7	477.2 ± 1474.5	0.478

RUQ: Right upper quadrant.